These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2421479)

  • 1. Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus.
    Cammack N; Gould EA
    Virology; 1986 Apr; 150(2):333-41. PubMed ID: 2421479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.
    Schlesinger JJ; Brandriss MW; Monath TP
    Virology; 1983 Feb; 125(1):8-17. PubMed ID: 6187129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools.
    Gould EA; Buckley A; Cane PA; Higgs S; Cammack N
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1889-94. PubMed ID: 2472467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 17D yellow fever virus envelope protein epitopes using monoclonal antibodies.
    Schlesinger JJ; Walsh EE; Brandriss MW
    J Gen Virol; 1984 Oct; 65 ( Pt 10)():1637-44. PubMed ID: 6208313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.
    Ryman KD; Ledger TN; Campbell GA; Watowich SJ; Barrett AD
    Virology; 1998 Apr; 244(1):59-65. PubMed ID: 9581778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes.
    Davis EH; Barrett ADT
    Viral Immunol; 2020; 33(1):12-21. PubMed ID: 31682201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Characterization of Yellow Fever Virus Wild-Type Strain Asibi, Parent to Live-Attenuated 17D Vaccine, from Three Different Sources.
    Davis EH; Thompson JK; Widen SG; Barrett ADT
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of wild-type yellow fever virus by passage in HeLa cells.
    Barrett AD; Monath TP; Cropp CB; Adkins JA; Ledger TN; Gould EA; Schlesinger JJ; Kinney RM; Trent DW
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2301-6. PubMed ID: 2230735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.
    Barrett AD; Mathews JH; Miller BR; Medlen AR; Ledger TN; Roehrig JT
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():13-8. PubMed ID: 1689367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.
    Barrett AD; Pryde A; Medlen AR; Ledger TN; Whitby JE; Gibson CA; DeSilva M; Groves DJ; Langley DJ; Minor PD
    Vaccine; 1989 Aug; 7(4):333-6. PubMed ID: 2479185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.
    Ledger TN; Sil BK; Wills MR; Lewis G; Kinney RM; Jennings AD; Stephenson JR; Barrett AD
    Biologicals; 1992 Jun; 20(2):117-28. PubMed ID: 1389107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a purified fragment of 17D yellow fever envelope protein.
    Brandriss MW; Schlesinger JJ; Walsh EE
    J Infect Dis; 1990 Jun; 161(6):1134-9. PubMed ID: 1693159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.
    Dunster LM; Wang H; Ryman KD; Miller BR; Watowich SJ; Minor PD; Barrett AD
    Virology; 1999 Sep; 261(2):309-18. PubMed ID: 10497116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain).
    Lobigs M; Dalgarno L; Schlesinger JJ; Weir RC
    Virology; 1987 Dec; 161(2):474-8. PubMed ID: 2446422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48.
    Schlesinger JJ; Brandriss MW; Walsh EE
    J Immunol; 1985 Oct; 135(4):2805-9. PubMed ID: 4031501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
    Adungo F; Yu F; Kamau D; Inoue S; Hayasaka D; Posadas-Herrera G; Sang R; Mwau M; Morita K
    Clin Vaccine Immunol; 2016 Aug; 23(8):689-97. PubMed ID: 27307452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic analysis of yellow fever virus glycoproteins: use of monoclonal antibodies in enzyme-linked immunosorbent assays.
    Cammack N; Gould EA
    J Virol Methods; 1986 May; 13(2):135-42. PubMed ID: 3016014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.